223 related articles for article (PubMed ID: 21942531)
1. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
Rothrock JF; Cady RK; Aurora SK; Brandes JL; Myers JA; Fox AW; Farr SJ
Curr Med Res Opin; 2011 Nov; 27(11):2185-91. PubMed ID: 21942531
[TBL] [Abstract][Full Text] [Related]
2. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
[TBL] [Abstract][Full Text] [Related]
3. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
4. Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headaches.
Freitag FG
Expert Rev Neurother; 2011 Apr; 11(4):481-90. PubMed ID: 21469920
[TBL] [Abstract][Full Text] [Related]
5. Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.
Landy S; Hoagland R; Hoagland NA
Headache; 2012 Jan; 52(1):133-9. PubMed ID: 21883200
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
7. A review of needle-free sumatriptan injection for rapid control of migraine.
Rothrock JF; Freitag FG; Farr SJ; Smith EF
Headache; 2013 Sep; 53 Suppl 2():21-33. PubMed ID: 24024600
[TBL] [Abstract][Full Text] [Related]
8. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
9. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
10. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
Smith T; Blumenthal H; Diamond M; Mauskop A; Ames M; McDonald S; Lener S; Burch S
Headache; 2007 May; 47(5):683-92. PubMed ID: 17501849
[TBL] [Abstract][Full Text] [Related]
11. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
[TBL] [Abstract][Full Text] [Related]
12. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
Winner P; Rothner AD; Wooten JD; Webster C; Ames M
Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
[TBL] [Abstract][Full Text] [Related]
13. Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain.
Silberstein SD; Newman LC; Marmura MJ; Nahas SJ; Farr SJ
Curr Med Res Opin; 2013 Jul; 29(7):861-7. PubMed ID: 23514092
[TBL] [Abstract][Full Text] [Related]
14. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
15. Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.
Landy SH; McGinnis JE; McDonald SA
Headache; 2005 Apr; 45(4):346-9. PubMed ID: 15836571
[TBL] [Abstract][Full Text] [Related]
16. Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment.
Revicki DA; Kimel M; Beusterien K; Kwong JW; Varner JA; Ames MH; Mahajan S; Cady RK
Headache; 2006 Feb; 46(2):240-52. PubMed ID: 16492233
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic applications for subcutaneous triptans in the acute treatment of migraine.
Erlichson K; Waight J
Curr Med Res Opin; 2012 Jul; 28(7):1231-8. PubMed ID: 22401601
[TBL] [Abstract][Full Text] [Related]
18. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
Burstein R; Collins B; Jakubowski M
Ann Neurol; 2004 Jan; 55(1):19-26. PubMed ID: 14705108
[TBL] [Abstract][Full Text] [Related]
19. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
Meadows KP; Pierce M; O'Neill C; Foster S; Jennings C
Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
[TBL] [Abstract][Full Text] [Related]
20. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
Winner P; Landy S; Richardson M; Ames M
Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]